477 related articles for article (PubMed ID: 27709612)
1. Alpha-lipoic acid-stearylamine conjugate-based solid lipid nanoparticles for tamoxifen delivery: formulation, optimization, in-vivo pharmacokinetic and hepatotoxicity study.
Dhaundiyal A; Jena SK; Samal SK; Sonvane B; Chand M; Sangamwar AT
J Pharm Pharmacol; 2016 Dec; 68(12):1535-1550. PubMed ID: 27709612
[TBL] [Abstract][Full Text] [Related]
2. Long chain lipid based tamoxifen NLC. Part I: preformulation studies, formulation development and physicochemical characterization.
Shete H; Patravale V
Int J Pharm; 2013 Sep; 454(1):573-83. PubMed ID: 23535345
[TBL] [Abstract][Full Text] [Related]
3. Long chain lipid based tamoxifen NLC. Part II: pharmacokinetic, biodistribution and in vitro anticancer efficacy studies.
Shete H; Chatterjee S; De A; Patravale V
Int J Pharm; 2013 Sep; 454(1):584-92. PubMed ID: 23535344
[TBL] [Abstract][Full Text] [Related]
4. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation.
Dudhipala N; Veerabrahma K
Drug Deliv; 2016; 23(2):395-404. PubMed ID: 24865287
[TBL] [Abstract][Full Text] [Related]
5. Effective cellular internalization, cell cycle arrest and improved pharmacokinetics of Tamoxifen by cholesterol based lipopolymeric nanoparticles.
Mazumdar S; Italiya KS; Sharma S; Chitkara D; Mittal A
Int J Pharm; 2018 May; 543(1-2):96-106. PubMed ID: 29578081
[TBL] [Abstract][Full Text] [Related]
6. Improved Oral Bioavailability, Therapeutic Efficacy, and Reduced Toxicity of Tamoxifen-Loaded Liquid Crystalline Nanoparticles.
Jain S; Heeralal B; Swami R; Swarnakar NK; Kushwah V
AAPS PharmSciTech; 2018 Jan; 19(1):460-469. PubMed ID: 28785860
[TBL] [Abstract][Full Text] [Related]
7. Self nanoprecipitating preconcentrate of tamoxifen citrate for enhanced bioavailability.
Kapse SV; Gaikwad RV; Samad A; Devarajan PV
Int J Pharm; 2012 Jun; 429(1-2):104-12. PubMed ID: 22414426
[TBL] [Abstract][Full Text] [Related]
8. Tamoxifen nanostructured lipid carriers: enhanced in vivo antitumor efficacy with reduced adverse drug effects.
Shete HK; Selkar N; Vanage GR; Patravale VB
Int J Pharm; 2014 Jul; 468(1-2):1-14. PubMed ID: 24704438
[TBL] [Abstract][Full Text] [Related]
9. Curcumin-loaded solid lipid nanoparticles with Brij78 and TPGS improved in vivo oral bioavailability and in situ intestinal absorption of curcumin.
Ji H; Tang J; Li M; Ren J; Zheng N; Wu L
Drug Deliv; 2016; 23(2):459-70. PubMed ID: 24892628
[TBL] [Abstract][Full Text] [Related]
10. Co-encapsulation of tamoxifen and quercetin in polymeric nanoparticles: implications on oral bioavailability, antitumor efficacy, and drug-induced toxicity.
Jain AK; Thanki K; Jain S
Mol Pharm; 2013 Sep; 10(9):3459-74. PubMed ID: 23927416
[TBL] [Abstract][Full Text] [Related]
11. Solid lipid nanoparticles loaded with lipoyl-memantine codrug: preparation and characterization.
Laserra S; Basit A; Sozio P; Marinelli L; Fornasari E; Cacciatore I; Ciulla M; Türkez H; Geyikoglu F; Di Stefano A
Int J Pharm; 2015 May; 485(1-2):183-91. PubMed ID: 25747452
[TBL] [Abstract][Full Text] [Related]
12. Polymeric micelles of amphiphilic graft copolymer of α-tocopherol succinate-g-carboxymethyl chitosan for tamoxifen delivery: Synthesis, characterization and in vivo pharmacokinetic study.
Jena SK; Sangamwar AT
Carbohydr Polym; 2016 Oct; 151():1162-1174. PubMed ID: 27474667
[TBL] [Abstract][Full Text] [Related]
13. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics.
Ji P; Yu T; Liu Y; Jiang J; Xu J; Zhao Y; Hao Y; Qiu Y; Zhao W; Wu C
Drug Des Devel Ther; 2016; 10():911-25. PubMed ID: 27041995
[TBL] [Abstract][Full Text] [Related]
14. Improved anti-hyperlipidemic activity of Rosuvastatin Calcium via lipid nanoparticles: Pharmacokinetic and pharmacodynamic evaluation.
Dudhipala N; Veerabrahma K
Eur J Pharm Biopharm; 2017 Jan; 110():47-57. PubMed ID: 27810472
[TBL] [Abstract][Full Text] [Related]
15. The effect of the oral administration of polymeric nanoparticles on the efficacy and toxicity of tamoxifen.
Jain AK; Swarnakar NK; Godugu C; Singh RP; Jain S
Biomaterials; 2011 Jan; 32(2):503-15. PubMed ID: 20934747
[TBL] [Abstract][Full Text] [Related]
16. Nano-formulation of rifampicin with enhanced bioavailability: development, characterization and in-vivo safety.
Singh H; Jindal S; Singh M; Sharma G; Kaur IP
Int J Pharm; 2015 May; 485(1-2):138-51. PubMed ID: 25769294
[TBL] [Abstract][Full Text] [Related]
17. Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization.
Liu J; Gong T; Wang C; Zhong Z; Zhang Z
Int J Pharm; 2007 Aug; 340(1-2):153-62. PubMed ID: 17428627
[TBL] [Abstract][Full Text] [Related]
18. Emodin loaded solid lipid nanoparticles: preparation, characterization and antitumor activity studies.
Wang S; Chen T; Chen R; Hu Y; Chen M; Wang Y
Int J Pharm; 2012 Jul; 430(1-2):238-46. PubMed ID: 22465546
[TBL] [Abstract][Full Text] [Related]
19. Solid lipid nanoparticles loaded with iron to overcome barriers for treatment of iron deficiency anemia.
Hosny KM; Banjar ZM; Hariri AH; Hassan AH
Drug Des Devel Ther; 2015; 9():313-20. PubMed ID: 25609917
[TBL] [Abstract][Full Text] [Related]
20. Preparation of an alternative freeze-dried pH-sensitive cyclosporine A loaded nanoparticles formulation and its pharmacokinetic profile in rats.
Yang ZQ; Xu J; Pan P; Zhang XN
Pharmazie; 2009 Jan; 64(1):26-31. PubMed ID: 19216227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]